We are live on ! Find out more
ENVB icon

Enveric Biosciences
ENVB

10 hedge funds and large institutions have $518K invested in Enveric Biosciences in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.01% more ownership

Funds ownership: 0.05% → 0.06% (+0.01%)

0% more funds holding

Funds holding: 10 → 10 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

18% less capital invested

Capital invested by funds: $631K → $518K (-$113K)

Holders
10
Holders Change
–
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AI
AdvisorShares Investments
Maryland
+$116K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$32.9K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$13.5K
4
TRCT
Tower Research Capital (TRC)
New York
+$3.15K
5
Osaic Holdings
Osaic Holdings
Arizona
+$901

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$58K
2
Citadel Advisors
Citadel Advisors
Florida
-$47K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
1
AdvisorShares Investments
Maryland
$339K +$116K +258 +46%
BlackRock
2
BlackRock
New York
$70.4K – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$42.9K +$13.5K +30 +43%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$30.3K +$32.9K +73 New
TRCT
5
Tower Research Capital (TRC)
New York
$22.9K +$3.15K +7 +15%
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$10K – – –
UBS Group
7
UBS Group
Switzerland
$740 +$901 +2 New
Osaic Holdings
8
Osaic Holdings
Arizona
$714 +$901 +2 New
Group One Trading
9
Group One Trading
Illinois
$631 – – –
Bank of America
10
Bank of America
North Carolina
$238 – – –
National Bank of Canada
11
National Bank of Canada
Quebec, Canada
$157 – – –
Toronto Dominion Bank
12
Toronto Dominion Bank
Ontario, Canada
$129 – – –
Wells Fargo
13
Wells Fargo
California
$81 – – –
Morgan Stanley
14
Morgan Stanley
New York
$2 – – –
Renaissance Technologies
15
Renaissance Technologies
New York
– -$58K -95 Closed
Citadel Advisors
16
Citadel Advisors
Florida
– -$47K -77 Closed
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
– -$1K -1 Closed

ENVB Hedge Fund Activity: Q3 2023 in Review

10 of the 6,303 institutional investors tracked by Wall St. Rank reported a position in Enveric Biosciences (ENVB) for Q3 2023, worth a combined $518K — down 18% from $631K a quarter earlier.

Fund positioning in ENVB was balanced in Q3 2023: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 0 trimmed.

The largest buyer was AdvisorShares Investments, adding an estimated $116K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $58K sold.

  • 10 institutional investors held Enveric Biosciences (ENVB) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $518K of Enveric Biosciences stock for Q3 2023, down 18% quarter-over-quarter.
  • 3 funds opened new Enveric Biosciences positions in Q3 2023 and 3 closed out, a net change of 0 holders.
  • The largest Enveric Biosciences buyer in Q3 2023 was AdvisorShares Investments, an estimated $116K added.
  • The largest Enveric Biosciences seller in Q3 2023 was Renaissance Technologies, an estimated $58K sold.

Based on aggregated 13F filings for Q3 2023.